References
- Rosen DR, Siddique T, Patterson D et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyo- trophic lateral sclerosis. Nature 1993; 362: 59–62.
- Hadano S, Hand CK, Osuga H et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet 2001; 29: 166–173.
- Yang Y, Hentati A, Deng HX et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet 2001; 29: 160–165.
- Eymard-Pierre E, Lesca G, Dollet G et al. Infantile-onset ascending hereditary spastic paralysis is associated with muta- tions in the alsin gene. Am J Hum Genet 2002; 71: 518–527.
- Veldink JH, van den Berg LH, Cobben JM et al. Homozygous deletion of the survival motor neuron 2 gene is a prognostic factor in sporadic ALS. Neurology 2001; 56: 749–752.
- Figlewicz DA, Krizus A, Martinoli MG et al. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet 1994; 3: 1757–1761.
- Tomkins J, Usher P, Slade JY et al. Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS). NeuroReport 1998; 9: 3967–3970.
- Al-Chalabi A, Enayat ZE, Bakker MC et al. Association of apolipoprotein E epsilon 4 allele with bulbar-onset motor neuron disease. Lancet 1996; 347: 159–160.
- McDermott CJ, White K, Bushby K et al. Hereditary spastic paraparesis: a review of new developments. J Neurol Neurosurg Psychiatry 2000; 69: 150–160.
- Fransen E, Lemmon V, Van Camp G et al. CRASH syndrome: clini- cal spectrum of corpus callosum hypoplasia, retardation, adducted thumbs, spastic paraparesis and hydrocephalus due to mutations in one single gene, L1. Eur J Hum Genet 1995; 3: 273–284.
- Kobayashi H, Hoffman EP, Marks HG. The rumpshaker mutation in spastic paraplegia. Nat Genet 1994; 7: 351–352.
- Hazan J, Fonknechten N, Mavel D et al. Spastin, a novel AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia. Nat Genet 1999; 23: 296–303.
- Zhao X, Alvarado D, Rainier S et al. Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia. Nat Genet 2001; 29: 326–331.
- Reid E, Kloos M, Ashley-Koch A et al. A kinesin heavy chain (KIF5A) mutation in hereditary pastic paraplegia (SPG10). Am J Hum Genet 2002;71.
- Casari G, De Fusco M, Ciarmatori S et al. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 1998; 93: 973–983.
- Patel H, Cross H, Proukakis C al et. SPG20 is mutated in Troyer syndrome, an hereditary spastic paraplegia. Nat Genet 2002; 31: 37–38.
- Shaw PJ, Tomkins J, Slade JY et al. CNS tissue Cu/Zn superoxide dismutase (SOD1) mutations in motor neurone disease (MND). NeuroReport 1997; 8: 3926–3927.
- McDermott CJ, Dayaratne RK, Tomkins J et al. Paraplegin gene analysis in hereditary spastic paraparesis (HSP) pedigrees in northeast England. Neurology 2001; 56: 467–471.
- Lindsey JC, Lusher ME, McDermott CJ et al. Mutation analysis of the spastin gene (SPG4) in patients with hereditary spastic paraparesis. J Med Genet 2000; 37: 759–765.
- Hentati A, Deng H-X, Zhai H et al. Novel mutations in spastin gene and absence of correlation with age at onset of symptoms. Neurology 2000; 55: 1388–1390.
- Burger J, Fonknechten N, Hoeltzenbein M et al. Hereditary spastic paraplegia caused by mutations in the SPG4 gene. Eur J Hum Gen 2000; 8: 771–776.
- Fonknechten N, Mavel D, Byrne P et al. Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia. Hum Mol Genet 2000; 9: 637–644.
- Namekawa M, Takiyama y, Sakoe K et al. A large Japanese SPG4 family with a novel insertion mutation of the SPG4 gene: a clinical and genetic study. J Neurol Sci 2001; 185: 63–68.
- Morita M, Ho M, Hosler BA et al. A novel mutation in the spastin gene in a family with spastic paraplegia. Neuroscience Letters 2002; 325: 57–61.
- Patrono C, Sasali C, Tessa A et al. Missense and splice site mutations in SPG4 suggest loss-of-function in dominant spastic paraplegia. J Neurol 2002; 249: 200–205.
- Mead SH, Proukakis C, Wood N et al. A large family with herditary spastic paraparesis due to a frame shift mutation of spastin (SPG4) gene: association with multiple sclerosis in two affected siblings and epilepsy in other affected family members. J Neurol Neurosurg Psychaitry 2001; 71: 788–791.
- Bantel A, McWilliams S, Auysh D et al. Novel mutation of the spastin gene in familial spastic paraplegia. Clin Genet 2001; 59: 364–365.
- Svenson IK, Ashley-Koch AE, Gaskell PG et al. Identification and expression analysis of spastin gene mutations in hereditary spastic paraplegia. Am J Hum Genet 2001; 68: 1077–1085.
- Meijer IA, Hand CK, Cossette P et al. Spectrum of SPG4 mutations in a large collection of North American families with hereditary spastic paraplegia. Arch Neurol 2002; 59: 281–286.
- Pringle CE, Hudson AJ, Munoz DG et al. Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain 1992; 115: 495–520.
- Nataraj AJ, Olivios-Glander I, Kusukawa N et al. Single- stranded conformation polymorphism and heteroduplex analysis for gel-based mutation detection. Electrophoresis 1999; 20: 1177–1185.